Table 2.

Risk-Adjusted Performance Measures According to Kidney Function Group

		Adjusted OR (95% C.I.)
	Mild vs. Normal	Moderate vs. Normal	Severe vs. Normal	Kidney failure vs. Normal
Discharge instructions*	0.99 (0.88, 1.11)	1.04 (0.91, 1.18)	1.01 (0.86, 1.19)	0.52 (0.43, 0.64)
Evaluation of LV systolic function*†	1.01 (0.81, 1.26)	1.04 (0.86, 1.26)	0.95 (0.73, 1.25)	0.44 (0.32, 0.62)
ACEI or ARB for LV systolic dysfunction*	0.80 (0.61, 1.04)	0.47 (0.36, 0.62)	0.19 (0.13, 0.28)	0.23 (0.14, 0.38)
Smoking cessation counseling*	1.15 (0.88, 1.51)	1.14 (0.87, 1.50)	1.10 (0.79, 1.53)	0.68 (0.34, 1.35)
β-blocker for LV systolic dysfunction	0.94 (0.59, 1.49)	0.79 (0.49, 1.25)	0.89 (0.56, 1.43)	0.57 (0.30, 1.09)
Composite performance measure (100% compliance*)	1.00 (0.89, 1.12)	0.92 (0.83, 1.03)	0.79 (0.68, 0.92)	0.45 (0.36, 0.56)
Warfarin for atrial fibrillation	0.98 (0.67, 1.44)	0.90 (0.63, 1.29)	0.65 (0.41, 1.02)	0.57 (0.33, 0.98)
β-blocker (Bisoprolol, Carvedilol, or Metoprolol XL) for LV systolic dysfunction	1.27 (1.04, 1.55)	1.12 (0.92, 1.37)	1.18 (0.91, 1.54)	0.63 (0.43, 0.91)
Discharge blood pressure < 140/90mmHg	0.77 (0.64, 0.92)	0.70 (0.58, 0.85)	0.52 (0.42, 0.63)	0.48 (0.38, 0.61)

Variables for risk-adjustment – age, gender, race, body mass index at admission, systolic blood pressure at admission, heart rate at admission, anemia, cerebrovascular disease, diabetes, hyperlipidemia, hypertension, pulmonary disease, peripheral vascular disease, coronary artery disease/ischemic etiology, ejection fraction (%).

^*Joint Commission and Centers for Medicaid and Medicare Services performance measure.

^†Evaluation of left ventricular systolic function was not adjusted for ejection fraction.